MDRejuvena releases Vivatia skin lightening products in US

Skin health and beauty products developer MDRejuvena has released its Vivatia range offering skin lightening products in the US.

Vivatia features technology designed to increase the dispersion and absorption of active ingredients into the skin. It is said to be clinically proven as an effective treatment for hyperpigmentation, anti-ageing, and photodamage.

Vivatia was previously marketed by PrecisionMD and later acquired by Valeant Pharmaceuticals.

MDRejuvena currently holds the exclusive, worldwide licence to the patents, trademarks, and know-how of the range.

MDRejuvena president and CEO Randy Kriech said: “Vivatia not only fills a significant void in the market place and within our current product portfolio, but it also provides us with another patented technology platform in which to further expand our already robust product pipeline.

"When Vivatia was previously on the market, it was well accepted by physicians and patients because of its effectiveness."

The range acts as a skin brightening system and includes a cleanser, a repair formula, and a brightening complex.

Formulated for cleaning dirt, impurities, and makeup, the Gentle Hydrating Cleanser preps the skin for the subsequent components.

The Active Repair Complex foam comprises a blend of stabilised retinol and anti-ageing ingredients such as antioxidants, peptides, and vitamins to minimise appearance of fine lines, wrinkles, and brown spots.